These approvals represent new hope in the fight against the world's number one ... the wider pharma industry. 10. Empliciti – part of a new generation of myeloma drugs No therapy area saw ...

Explore how Medicare drug price negotiations under the Inflation Reduction Act could evolve with the Trump administration.

The Janus Henderson Global Life Sciences Fund returned -11.16% and the MSCI World Health Care IndexSM returned -11.40%. Click ...

When the market learned the truth about Regeneron, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and specializes in ...

LOS ANGELES, CA / ACCESS Newswire / February 10 ... Regeneron, investors suffered damages. Join the case to recover your losses. The Schall Law Firm represents investors around the world and ...

A more complete description of these and other material risks can be found in Regeneron’s filings with the U.S. Securities and Exchange Commission, including its Form 10-K for the year ended ...

Regeneron's pipeline doesn't currently include a clinical-stage treatment for Parkinson's. but it is working on drugs for other neurodegenerative disorders, including amyotrophic lateral sclerosis ...

Medicare’s newly negotiated prices for these 10 drugs are on average 22% lower than ... while also reviewing real-world evidence (when available) to “holistically” assess such evidence.

The issue has escalated to a major point of geopolitical tension between the US and China and was the pretext given by US President Donald Trump for imposing 10 per cent tariffs on all Chinese ...

Objectives To describe the prescribing trends of antihypertensive drugs in primary care patients and assess the ... few studies have investigated the application of these guidelines in real-world ...

Immunology superstar Dupixent, which first brought Regeneron and Sanofi together in 2007, has entered its megablockbuster era ...